BioRestorative Therapies, Inc. Stock Other OTC
Stocks
BRTX
US0906554086
Biotechnology & Medical Research
| Market Cap | 5.2M 4.5M 4.2M 3.85M 7.24M 495M 7.36M 49.26M 19.33M 248M 19.52M 19.09M 820M | P/E 2026 * |
-0.41x | P/E 2027 * | -0.5x |
|---|---|---|---|---|---|
| Enterprise Value | 5.2M 4.5M 4.2M 3.85M 7.24M 495M 7.36M 49.26M 19.33M 248M 19.52M 19.09M 820M | EV / Sales 2026 * |
3.7x | EV / Sales 2027 * | 2.25x |
| Free-Float |
89.63% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioRestorative Therapies, Inc.
| 1 day | +1.08% |
| Manager | Title | Age | Since |
|---|---|---|---|
Katharyn Field
CEO | Chief Executive Officer | 32 | 13/07/2026 |
Rory Rumore
IRC | Investor Relations Contact | - | - |
Crystal Romano
PRN | Corporate Officer/Principal | - | 22/10/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Mika Grasso
BRD | Director/Board Member | 28 | 12/06/2026 |
Jay Dhaliwal
BRD | Director/Board Member | 37 | 12/06/2026 |
Esha Randhawa
BRD | Director/Board Member | - | 13/07/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.08% | +0.25% | - | - | 5.2M | |
| +8.49% | +20.55% | +70.77% | +110.32% | 68.12B | |
| +1.25% | +2.44% | +34.27% | +70.43% | 55.18B | |
| -1.09% | +32.96% | +19.67% | +494.56% | 28.63B | |
| +10.83% | +18.38% | +56.20% | +6.03% | 23.99B | |
| +2.72% | +3.41% | -16.11% | -7.96% | 23.53B | |
| +6.50% | +7.56% | +44.65% | -21.73% | 18.45B | |
| +6.20% | +11.51% | +33.87% | +693.38% | 16.44B | |
| -3.88% | +16.98% | +199.30% | +359.77% | 15.83B | |
| +3.58% | +1.96% | +43.35% | +163.76% | 13.4B | |
| Average | +3.57% | +11.68% | +54.00% | +207.62% | 29.28B | |
| Weighted average by Cap. | +4.36% | +13.10% | +50.69% | +168.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.4M 1.22M 1.13M 1.04M 1.96M 134M 1.99M 13.32M 5.23M 67.02M 5.28M 5.16M 222M | 2.31M 2M 1.87M 1.71M 3.22M 220M 3.27M 21.92M 8.6M 110M 8.68M 8.49M 365M |
| Net income | -13.52M -11.7M -10.92M -10.02M -18.85M -1.29B -19.15M -128M -50.3M -645M -50.78M -49.67M -2.13B | -15.56M -13.46M -12.57M -11.53M -21.68M -1.48B -22.03M -147M -57.87M -742M -58.43M -57.15M -2.45B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
